Intersphincteric resection (ISR) improved five-year overall survival in ultra-low rectal cancer (ULRC) by 6.7% compared to traditional abdominoperineal resection (APR), achieving an 80.8% survival rate. Over a median follow-up of 47.2 months, ISR demonstrated similar surgical complications and hospital stays as APR, solidifying its role as a viable treatment option that preserves anal function and enhances quality of life for patients facing this challenging diagnosis.
Journal Article by Wang GC, Chen JX (…) Huang Y et 3 al. in World J Gastroenterol
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.